✦ LIBER ✦

Oral high-dose medroxyprogesterone acetate versus tamoxifen: A randomized crossover trial in postmenopausal patients with advanced breast cancer

✍ Scribed by Hendrik Van Veelen; Pax H. B. Willemse; Tonnis Tjabbes; Marjan J. H. Schweitzer; Dirk Th. Sleijfer

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 579 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860701)58:1<7::aid-cncr2820580103>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III trial of oral high-dose medr

A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer

✍ Masaru Izuo; Minoru Yoshida; Takeshi Tominaga; Osahiko Abe; Koji Enomoto; Yasuo 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Tamoxifen plus sequential CMF chemothera

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: A randomized trial

✍ John H. Glick; Richard H. Creech; Susan Torri; Christopher Holroyde; Harvey Brod 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

A randomized comparative trial of combin

A randomized comparative trial of combined versus alternating therapy with cytostatic drugs and high-dose medroxyprogesteron acetate in advanced breast cancer

✍ Jacques A. Wils; Hein Bron; Leo Van Lange; Martin Pannebakker; Anton Romme; Herm 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Chemotherapy versus chemotherapy plus ho

Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients a randomized trial

✍ Pablo Viladiu; Maria Carmen Alonso; Antonio Avella; Miguel Beltrán; Juan Borrás; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

High-dose medroxyprogesterone acetate in

High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen

✍ Reinhard Becher; Antonius A. Miller; Klaus Höffken; Udo Gerhold; Herbert Hirche; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/